|
Treatment
|
Males
|
%
|
Females D
|
%
|
Total (males and females)
|
%
|
OR (F)
|
CL 95%
|
Χ2 1df
|
P
|
|---|
|
First-line Antidepressants°
|
2
|
6.8
|
18
|
16.6
|
20
|
14.6
|
2.7
|
0.1-96.4
|
1.05
|
0.30
|
|
Second-line Antidepressants§
|
1
|
3.4
|
6
|
5.6
|
7
|
5.1
|
1.6
|
0.1-31.2
|
0.1
|
0.98
|
|
Benzodiazepines*
|
7
|
24.1
|
33
|
30.6
|
40
|
24.1
|
1.4
|
0.2-6.3
|
0.2
|
0.66
|
|
Homeopathics
|
1
|
3.4
|
3
|
2.7
|
4
|
2.9
|
0.8
|
0.3-2.1
|
0.2
|
0.68
|
|
Psychotherapy
|
3
|
10.3
|
10
|
9.2
|
13
|
9.5
|
0.9
|
0.4-2.0
|
0.1
|
0.86
|
- °SSRI, TCA, IMAO, SNRI, NaSSA, bupriopion; § low-dosage benzamides, low-dosage quetiapine, trazodone, nefazodone, Adenosin-methionine, Hypericum Perforatum
